Modified Oscor Py Pacing Leads/Modification
510(k) K913158
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK913158 | Date23 Sep 1991 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DTB
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3680
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Modified Oscor PY Pacing Leads are classified as Permanent Pacemaker Electrodes, designed for use in cardiac pacing systems. These leads deliver electrical impulses to stimulate the heart, ensuring proper rhythm and function in patients requiring pacemaker therapy.
These leads are intended for single-use and are supplied sterile for direct implantation during cardiac procedures. They are regulated under FDA 510K clearance (K913158) and fall under device classification DTB, adhering to regulatory standards for cardiovascular devices. Multiple reference codes (e.g., 3002618605, 1028232) identify variations in lead specifications, ensuring compatibility with various pacemaker systems.
Other devices from Oscor Medical Corp.
Questions
AI-generated answers, 18 Sep 2026
Are these pacing leads designed for reuse in multiple patients, or are they intended for single-use only?
These Modified Oscor PY Pacing Leads are explicitly intended for single-use only and are supplied sterile for direct implantation. The device description and FDA 510K submission emphasize their sterile packaging and intended use in a single cardiac procedure to ensure patient safety and compliance with medical device standards.
What types of pacemaker systems are these leads compatible with, and how do I determine the correct model for my patient?
These leads are designed for compatibility with various pacemaker systems, as indicated by the multiple OpenFDA reference codes (e.g., 3002618605, 1028232, etc.). To select the correct model, verify the specific lead specifications (e.g., electrode type, coil configuration, or connector size) against your pacemaker system’s requirements. The manufacturer’s documentation or a clinical specialist can assist in matching the right lead to your patient’s device.
How should these leads be stored before use, and what precautions should be taken to maintain sterility?
Since these leads are sterile upon packaging, they must be stored in their original, unopened packaging to preserve sterility. The packaging should be kept in a clean, dry environment away from direct sunlight or extreme temperatures. Avoid contamination by ensuring the sterile barrier is intact until immediate pre-procedure preparation. Always follow the manufacturer’s storage guidelines to prevent degradation or compromise of sterility.
What regulatory pathway was followed for FDA clearance of these leads, and what does that mean for clinical use?
These leads were cleared through the FDA 510K pathway (K913158), specifically under the Traditional review process with a Substantially Equivalent (SESE) determination. This means the device was compared to a legally marketed predicate and deemed equivalent in safety and effectiveness for its intended use as a permanent pacemaker electrode. Clinically, this clearance confirms the leads meet FDA standards for cardiac pacing applications, but always verify compatibility with your facility’s protocols and the specific pacemaker system in use.